Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 8/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.61 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.61 |
| ▸ | KDR | P35968 | 3/20 | 0.56 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | KIF11 | P52732 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26547979 | 1.00 | CYP11B2 (0.61) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548587 | 0.95 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548901 | 0.95 | CYP11B2 (0.59) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26547967 | 0.91 | CYP11B2 (0.65) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548400 | 0.91 | CYP11B2 (0.65) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548201 | 0.89 | CYP11B2 (0.52) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL15649790 | 0.89 | KDR (0.59) | KDRDGAT1KCNH2FGFR1EGFR | |
| SCHEMBL26549063 | 0.88 | CYP2A6 (0.55) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26549356 | 0.88 | CYP2A6 (0.55) | CYP11B2CYP11B1CYP19A1CYP17A1KDR | |
| SCHEMBL26548895 | 0.86 | CYP11B2 (0.63) | CYP11B2CYP11B1CYP19A1CYP17A1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | CYP11B2 1913/4885CYP11B1 1676/4885CYP19A1 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.